Nuzenio

Aim Immunotech

Aim Immunotech news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 5 publisher sources 100/100 entity strength

Latest news

AIM ImmunoTech (NYSE: AIM) returns to positive equity after new financings - Stock TitanStock Titan · Fri, 07 Aug 2026 20:36:50 GMT AIM ImmunoTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 20:36:00 GMT AIM ImmunoTech Inc (AIM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 18:20:47 GMT AIM ImmunoTech completes last dose in Phase 2 p... - PluangPluang · Mon, 03 Aug 2026 13:27:47 GMT AIM ImmunoTech Ahead of Schedule on ‘Last Dose’ DURIPANC Critical Clinical Inflection Point - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:33:00 GMT AIM ImmunoTech Inc (AIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKeyTradingKey · Mon, 27 Jul 2026 16:01:41 GMT AIM ImmunoTech Inc (AIM) Balance Sheet - TradingKeyTradingKey · Mon, 27 Jul 2026 15:36:24 GMT AIM ImmunoTech Inc (AIM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKeyTradingKey · Mon, 27 Jul 2026 14:46:13 GMT

Timeline

Fri, 07 Aug 2026 20:36:50 GMTAIM ImmunoTech (NYSE: AIM) returns to positive equity after new financings - Stock Titan

Fri, 07 Aug 2026 20:36:00 GMTAIM ImmunoTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Fri, 07 Aug 2026 18:20:47 GMTAIM ImmunoTech Inc (AIM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Mon, 03 Aug 2026 13:27:47 GMTAIM ImmunoTech completes last dose in Phase 2 p... - Pluang

Mon, 03 Aug 2026 12:33:00 GMTAIM ImmunoTech Ahead of Schedule on ‘Last Dose’ DURIPANC Critical Clinical Inflection Point - Yahoo Finance

Mon, 27 Jul 2026 16:01:41 GMTAIM ImmunoTech Inc (AIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

AIM10 live mentions AIM ImmunoTech Inc6 live mentions TradingKey AIM ImmunoTech4 live mentions Inc4 live mentions TradingKey3 live mentions NYSE2 live mentions Reports Earnings Results2 live mentions Second Quarter2 live mentions Six Months Ended2 live mentions June2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Aim Immunotech.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.